Switching Costs, Brand Premia and Behavioral Pricing in the Pharmaceutical Market
Year of publication: |
2020
|
---|---|
Authors: | Janssen, Aljoscha |
Publisher: |
[S.l.] : SSRN |
Subject: | Markenartikel | Brand | Wechselverhalten | Switching behaviour | Pharmaindustrie | Pharmaceutical industry | Preismanagement | Pricing strategy | Arzneimittel | Pharmaceuticals | Arzneimittelmarkt | Pharmaceutical market | Konsumentenverhalten | Consumer behaviour | Markenführung | Brand management | Generika | Generic drugs |
Extent: | 1 Online-Ressource (49 p) |
---|---|
Series: | IFN Working Paper ; No. 1317 (2020) |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments May 20, 2020 erstellt |
Other identifiers: | 10.2139/ssrn.3644348 [DOI] |
Classification: | D12 - Consumer Economics: Empirical Analysis ; I11 - Analysis of Health Care Markets ; L13 - Oligopoly and Other Imperfect Markets |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Switching costs, brand premia and behavioral pricing in the pharmaceutical market
Janssen, Aljoscha, (2020)
-
Collusion in the US generic drug industry
Clark, Robert, (2021)
-
Umbrella Branding in Pharmaceutical Markets
Suppliet, Moritz, (2017)
- More ...
-
Pregnancy persistently reduces alcohol purchases : Causal evidence from scanner data
Janssen, Aljoscha, (2020)
-
Obfuscation and rational inattention in digitalized markets
Janssen, Aljoscha, (2021)
-
The importance of the first generic substitution: Evidence from Sweden
Janssen, Aljoscha, (2022)
- More ...